#JPM22: Catalent CEO John Chiminski with John Carroll — Our predictions for the biopharma industry in 2022

During our JPM22 week of events, I had a chance to sit down with Catalent CEO John Chiminski for our annual forecast for the year ahead. It’s always a lot of fun, and Chiminski had a chance to talk about the big transition ahead for his company, CDMOs, and...

Click to view original post